Predilife S.A [ALPRE] vs Eurofins Scientific [ERF] Detailed Stock Comparison

Predilife S.A.

EURONEXT
Loading...

Eurofins Scientific SE

EURONEXT
Loading...

TLDR: Quick Comparison Summary

Based on 18 vital metrics comparison: Predilife S.A. wins in 2 metrics, Eurofins Scientific SE wins in 12 metrics, with 0 ties. Eurofins Scientific SE appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Predilife S.A. Eurofins Scientific SE Better
P/E Ratio (TTM) N/A 24.24 N/A
Price-to-Book Ratio N/A 3.08 N/A
Debt-to-Equity Ratio -1.15 96.84 Eurofins Scientific SE
EV/EBITDA -4.63 10.05 Eurofins Scientific SE
Profit Margin (TTM) 97.76% 6.51% Predilife S.A.
Operating Margin (TTM) -402.94% 13.25% Eurofins Scientific SE
EBITDA Margin (TTM) N/A 13.25% N/A
Return on Equity -4,653.75% 9.50% Eurofins Scientific SE
Return on Assets (TTM) -116.19% 5.51% Eurofins Scientific SE
Free Cash Flow (TTM) $-3.73M $564.10M Eurofins Scientific SE
Dividend Yield N/A 1.82% N/A
1-Year Return -25.90% 6.33% Eurofins Scientific SE
Price-to-Sales Ratio (TTM) 16.78 1.48 Eurofins Scientific SE
Enterprise Value $15.90M $14.63B Eurofins Scientific SE
EV/Revenue Ratio 21.83 2.01 Eurofins Scientific SE
Revenue per Share (TTM) $0 $41 Eurofins Scientific SE
Earnings per Share (Diluted) $-1.06 $2.55 Eurofins Scientific SE
Beta (Stock Volatility) 0.27 0.91 Predilife S.A.

Predilife S.A. vs Eurofins Scientific SE Stock Performance Analysis

Loading Price Chart...

ALPRE
ERF

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Predilife S.A.-6.67%-1.72%-4.36%-10.38%-16.18%-10.09%
Eurofins Scientific SE0.72%-1.00%6.01%-9.69%3.34%-1.06%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Predilife S.A.-25.90%-47.45%-55.88%-68.92%-68.92%-68.92%
Eurofins Scientific SE6.33%1.40%-25.89%-81.78%-31.27%-31.27%

Performance & Financial Health Analysis: Predilife S.A. vs Eurofins Scientific SE

MetricALPREERF
Market Information
Market Cap i€12.22M€10.82B
Market Cap CategorySmall capLarge cap
10 Day Avg. Volume i977363,779
90 Day Avg. Volume i1,065349,425
Last Close€2.66€61.78
52 Week Range€2.50 - €4.00€54.86 - €74.32
% from 52W High-33.50%-16.87%
All-Time High€24.00 (Apr 29, 2024)€620.20 (May 25, 2020)
% from All-Time High-88.92%-90.04%
Growth Metrics
Quarterly Revenue Growth1.49%0.04%
Quarterly Earnings GrowthN/A0.23%
Financial Health
Profit Margin (TTM) i0.98%0.07%
Operating Margin (TTM) i-4.03%0.13%
Return on Equity (TTM) i-46.54%0.10%
Debt to Equity (MRQ) i-1.1596.84
Cash & Liquidity
Book Value per Share (MRQ)€-4.00€20.05
Cash per Share (MRQ)€0.12€4.50
Operating Cash Flow (TTM) i€-2,783,342€1.40B
Levered Free Cash Flow (TTM) i€-1,267,539€492.52M
Dividends
Last 12-Month Dividend Yield iN/A1.82%
Last 12-Month Dividend iN/A€1.10

Valuation & Enterprise Metrics Analysis: Predilife S.A. vs Eurofins Scientific SE

MetricALPRE (Apr 26, 2026)ERF (Apr 26, 2026)
Price Ratios
P/E Ratio (TTM) iN/A24.24
Forward P/E i-2.0313.25
PEG Ratio iN/AN/A
Price to Sales (TTM) i16.781.48
Price to Book (MRQ) iN/A3.08
Market Capitalization
Market Capitalization i€12.22M€10.82B
Enterprise Value i€15.90M€14.63B
Enterprise Value Metrics
Enterprise to Revenue i21.832.01
Enterprise to EBITDA i-4.6310.05
Risk & Other Metrics
Beta i0.270.91
Book Value per Share (MRQ) i€-4.00€20.05

Financial Statements Comparison: Predilife S.A. vs Eurofins Scientific SE

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricALPRE (2024)ERF (2025)
Revenue/Sales i618,0587.30B
Cost of Goods Sold i13,8192.33B
COGS % of Revenue i2.2%31.9%
Gross Profit i604,2394.97B
Gross Margin i97.8%68.1%
Research & Development iN/AN/A
Operating Income (EBIT) i-3.99M818.30M
Operating Margin i-645.0%11.2%
EBITDA i-3.95M1.58B
EBITDA Margin i-639.5%21.6%
Pre-Tax Income i-4.83M654.10M
Pre-Tax Income % of Revenue i-781.4%9.0%
Income Tax i-342,366181.10M
Income Tax % of Revenue i-55.4%2.5%
Net Income (Profit) i198.63M473.00M
Profit Margin i32,137.4%6.5%

Balance Sheet & Liquidity Metrics

MetricALPRE (2024)ERF (2025)
Cash & Equivalents i1.06M791.20M
Total Current Assets i1.99M2.65B
Total Current Assets % of Revenue i321.3%36.4%
Total Current Liabilities i1.69M2.43B
Total Current Liabilities % of Revenue i274.0%33.3%
Long-Term Debt i4.45M3.71B
Long-Term Debt % of Revenue i720.6%50.8%
Total Shareholders Equity i-4.27M4.58B
Retained Earnings i-4.26M3.02B
Retained Earnings % of Revenue i-690.0%41.4%
Property, Plant & Equipment i18,66087.00M

Cash Flow Statement Comparison

MetricALPRE (2024)ERF (2025)
Operating Cash Flow i-4.26M893.70M
Operating Cash Flow % of Revenue i-690.0%12.2%
Capital Expenditures i-5,395-745.70M
Free Cash Flow i-3.73M564.10M
FCF Margin i-603.0%7.7%
Debt Repayment i-2.37M-310.90M
Common Stock Repurchase iN/A-541.30M

Short Interest & Institutional Ownership Analysis

MetricALPREERF
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i3.75M176.70M
Float Shares iN/A112.89M
% Held by Insiders i69.05%36.50%
% Held by Institutions i0.00%34.99%
% Held by Public i30.95%28.51%

Dividend Analysis & Yield Comparison: Predilife S.A. vs Eurofins Scientific SE

MetricALPREERF
Last 12-Month Dividend iN/A€1.10
Last 12-Month Dividend Yield iN/A1.82%
3-Year Avg Annual Dividend iN/A€1.03
3-Year Avg Dividend Yield iN/A1.29%
3-Year Total Dividends iN/A€3.10
Ex-Dividend DateN/AApr 28, 2025